Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin

Diabetes Care - United States
doi 10.2337/dc14-2364
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Empagliflozin and Metformin Combination Therapy in Type 2 Diabetes Mellitus

International Journal of Basic and Clinical Pharmacology
2015English

Combination of Empagliflozin and Metformin Therapy: A Consideration of Its Place in Type 2 Diabetes Therapy

Clinical Medicine Insights: Endocrinology and Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Comparison of Nateglinide and Gliclazide in Combination With Metformin, for Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Maximum Doses of Metformin Alone

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2006English

Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2007English

Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus

JAMA - Journal of the American Medical Association
Medicine
2000English

Efficiency and Safety of Transfer of Type 2 Diabetes Patients Inadequately Controlled on Metformin Alone to Combined Therapy Withmetformin and Diabeton MB

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2009English

Metformin as First-Line Treatment for Type 2 Diabetes

The Lancet
Medicine
2018English

A Phase 3 Randomized Placebo-Controlled Trial to Assess the Efficacy and Safety of Ipragliflozin as an Add-On Therapy to Metformin in Russian Patients With Inadequately Controlled Type 2 Diabetes Mellitus

Diabetes Research and Clinical Practice
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2018English

Cost-Effectiveness of Saxagliptin and Linagliptin in Combination With Metformin for Type II Diabetes: A Decision-Tree Analysis Model

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy